Intratumoral Heterogeneity of MicroRNA Expression in Rectal Cancer.

Intratumoral Heterogeneity of MicroRNA Expression in Rectal Cancer.

INTRODUCTION:An increasing number of studies have investigated microRNAs (miRNAs) as potential markers of diagnosis, treatment and prognosis. So far, agreement between studies has been minimal, which may in part be explained by intratumoral heterogeneity of miRNA expression. The aim of the present s...

Full description

Bibliographic Details
Main Authors:	Anne Haahr Mellergaard Eriksen, Rikke Fredslund Andersen, Boye Schnack Nielsen, Flemming Brandt Sørensen, Ane Lindegaard Appelt, Anders Jakobsen, Torben Frøstrup Hansen
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4892647?pdf=render

Similar Items

MicroRNA Expression Profiling to Identify and Validate Reference Genes for the Relative Quantification of microRNA in Rectal Cancer.
by: Anne Haahr Mellergaard Eriksen, et al.
Published: (2016-01-01)

The Clinical Impact of MicroRNA-21 in Low Rectal Cancer Treated with High-Dose Chemoradiotherapy in the Organ Preserving Setting
by: Caroline Brenner Thomsen, et al.
Published: (2020-10-01)

Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab
by: Torben Frøstrup Hansen, et al.
Published: (2017-05-01)

MicroRNA-200b is downregulated in colon cancer budding cells.
by: Kirsten Nguyen Knudsen, et al.
Published: (2017-01-01)

microRNA-17 Is the Most Up-Regulated Member of the miR-17-92 Cluster during Early Colon Cancer Evolution.
by: Kirsten Nguyen Knudsen, et al.
Published: (2015-01-01)

The predictive value of microRNA-126 in relation to first line treatment with capecitabine and oxaliplatin in patients with metastatic colorectal cancer
by: Hansen Torben, et al.
Published: (2012-03-01)

Heterogeneity of miRNA expression in localized prostate cancer with clinicopathological correlations.
by: Ahmed Hussein Zedan, et al.
Published: (2017-01-01)

Tertiary Intratumor Lymphoid Tissue in Colo-Rectal Cancer
by: Federica Marchesi, et al.
Published: (2011-12-01)

Developing recombinant poxvirus vaccines
by: Fredslund Andersen, Rikke
Published: (2005)

The Effects of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer—The Impact in Intratumoral Heterogeneity
by: Fabiana Bettoni, et al.
Published: (2019-09-01)

<i>NPY</i> Gene Methylation as a Universal, Longitudinal Plasma Marker for Evaluating the Clinical Benefit from Last-Line Treatment with Regorafenib in Metastatic Colorectal Cancer
by: Lars Henrik Jensen, et al.
Published: (2019-10-01)

Circulating free DNA as biomarker and source for mutation detection in metastatic colorectal cancer.
by: Karen Lise Garm Spindler, et al.
Published: (2015-01-01)

Validating Methylated HOXA9 in Bronchial Lavage as a Diagnostic Tool in Patients Suspected of Lung Cancer
by: Sara W. C. Wen, et al.
Published: (2021-08-01)

Intratumoral heterogeneity
by: Filip Vuletić, et al.
Published: (2018-02-01)

Learning based on patient case reviews: an interview study
by: Søndergaard Jens, et al.
Published: (2008-09-01)

Quantification of Cell-free HER-2 DNA in Plasma from Breast Cancer Patients: Sensitivity for Detection of Metastatic Recurrence and Gene Amplification
by: Patricia Diana Sørensen, et al.
Published: (2015-08-01)

Quantification of Cell-Free HER-2 DNA in Plasma from Breast Cancer Patients: Sensitivity for Detection of Metastatic Recurrence and Gene Amplification
by: Patricia Diana Sørensen, et al.
Published: (2015-08-01)

Angiogenesis Inhibitors for Colorectal Cancer. A Review of the Clinical Data
by: Torben Frøstrup Hansen, et al.
Published: (2021-03-01)

Early identification of treatment benefit by methylated circulating tumor DNA in metastatic colorectal cancer
by: Caroline B. Thomsen, et al.
Published: (2020-05-01)

Patient delay in colorectal cancer patients: associations with rectal bleeding and thoughts about cancer.
by: Anette F Pedersen, et al.
Published: (2013-01-01)

Intratumoral heterogeneity in Endometrial Carcinomas
by: Cátia Daniela Carvalho da Silva
Published: (2019)

Evolutionary dynamics of intratumor heterogeneity.
by: Yoh Iwasa, et al.
Published: (2011-03-01)

Intratumor and Intertumor Heterogeneity in Melanoma
by: Tomasz M. Grzywa, et al.
Published: (2017-12-01)

Quantification of microRNA in plasma using probe based TaqMan assays: is microRNA purification required?
by: Helle Glud Binderup, et al.
Published: (2019-05-01)

Intratumoral HLA-DR−/CD33+/CD11b+ Myeloid-Derived Suppressor Cells Predict Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
by: Erez Hasnis, et al.
Published: (2020-08-01)

Is there a relation between the changes in circulating lymphocyte counts due to neoadjuvant chemoradiotherapy and intratumoral lymphocytic response and tumor regression grade in locally advanced rectal cancers?
by: Necdet Fatih Yasar, et al.
Published: (2017-12-01)

Retroperitoneal ganglioneuroblastoma in an adult with intratumoral bleed
by: K K Sabharwal, et al.
Published: (2006-05-01)

Targeting intratumoral androgens: statins and beyond
by: Michael T. Schweizer, et al.
Published: (2016-09-01)

Intratumor Heterogeneity in Early Lung Adenocarcinoma
by: Maria-Fernanda Senosain, et al.
Published: (2020-03-01)

Measuring Intratumoral Heterogeneity of Immune Repertoires
by: Diana Vladimirovna Yuzhakova, et al.
Published: (2020-05-01)

Towards inverse modeling of intratumor heterogeneity
by: Brutovsky Branislav, et al.
Published: (2015-08-01)

Intratumoral Bleeding in a Vestibular Schwannoma
by: Emanuelle Rieger Braga, et al.
Published: (2018-03-01)

The Prognostic Value of Haplotypes in the Vascular Endothelial Growth Factor A Gene in Colorectal Cancer
by: Torben F. Hansen, et al.
Published: (2010-06-01)

Comparison of Mutated KRAS and Methylated HOXA9 Tumor-Specific DNA in Advanced Lung Adenocarcinoma
by: Sara W. C. Wen, et al.
Published: (2020-12-01)

Computer-assisted stereology and automated image analysis for quantification of tumor infiltrating lymphocytes in colon cancer
by: Ann C. Eriksen, et al.
Published: (2017-08-01)

Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer?
by: Ann C. Eriksen, et al.
Published: (2018-03-01)

Repurposing the yellow fever vaccine for intratumoral immunotherapy
by: Maria Angela Aznar, et al.
Published: (2020-01-01)

Repurposing infectious disease vaccines for intratumoral immunotherapy
by: Christophe Caux, et al.
Published: (2020-06-01)

Intratumoral heterogeneity and clonal evolution in liver cancer
by: Bojan Losic, et al.
Published: (2020-01-01)

Clinical significance of intratumor heterogeneity for gynecological carcinoma
by: Ying-Chao Yang, et al.
Published: (2015-03-01)